Janice M Scott, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 8629 Bluejacket St, Suite 102, Lenexa, KS 66214 Phone: 913-677-0500 Fax: 913-677-5243 |
Loise Wameithi, PMHNP Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 13830 Santa Fe Trail Dr Ste 109, Lenexa, KS 66215 Phone: 913-295-2232 |
Mrs. Teresa Varanka, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 8629 Bluejacket St, Suite 100, Lenexa, KS 66214 Phone: 913-677-3553 Fax: 913-677-3282 |
Guillermo Ibarra, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 8629 Bluejacket St, Lenexa, KS 66214 Phone: 913-677-0500 Fax: 913-677-5243 |
Dr. Dana M Winegarner, DO Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 8550 Marshall Dr, Ste 100, Lenexa, KS 66214 Phone: 913-894-1500 Fax: 913-894-1502 |
Dr. Vernon D Rowe, MD Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 8550 Marshall Dr Ste 100, Lenexa, KS 66214 Phone: 913-827-4200 Fax: 913-827-4201 |
Dr. Jason Joseph Miiller, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 21809 W 95th Ter, Lenexa, KS 66220 Phone: 763-258-7760 |
Dr. Jeffrey M Kaplan, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 12208 W 87th Street Pkwy, Suite 180, Lenexa, KS 66215 Phone: 913-438-0868 Fax: 913-338-1311 |
Basuviah Shanker, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 8629 Bluejacket St, Suite 102, Lenexa, KS 66214 Phone: 913-677-0500 Fax: 913-677-5243 |
News Archive
A new study has uncovered an increased risk of dementia-in particular Alzheimer's disease-in patients with rosacea. Importantly, the risk was highest in older patients and in patients where rosacea was diagnosed by a hospital dermatologist. The findings are published in the Annals of Neurology, a journal of the American Neurological Association and Child Neurology Society.
Hemispherx Biopharma, Inc. announced today that the Food and Drug Administration (FDA) granted a 12 month extension for the Company to modify its NDA in response to a Complete Response Letter (CRL) received November 25, 2009 for the CFS indication.
Agena Bioscience today introduced the Chip prep module to automate sample handling after PCR for the MassARRAY 96-well System. This enables laboratories to operate the MassARRAY System largely unattended for high-throughput, multiplex genetic analysis.
Children with known skin, food and respiratory allergies should be screened for an emerging, chronic food allergy called eosinophilic esophagitis, a painful inflammation of the esophagus, the food tube between the mouth and stomach.
› Verified 1 days ago